Author

Paul J. Silver

Observed names: P J Silver, P. J. SILVER, P. J. Silver, P. Silver, P.J. Silver, PAUL J. SILVER, Paul J Silver, Paul Silver

Institution: Wyeth

Observed institutions: Carestream (United States), Sterling Research Group, Kodak (United States), Wyeth, Janssen Research & Development (United States), University of Duisburg-Essen, University of Cincinnati, The University of Texas Southwestern Medical Center, Michigan State University

OpenAlex ID: A5057009261

Drug action and cellular calcium regulation

1987 · Ronald A. Janis, Paul J. Silver, et al. · Advances in Drug Research · 201

Regulation of myosin light chain and phosphorylase phosphorylation in tracheal smooth muscle.

1982 · P J Silver, J T Stull · Journal of Biological Chemistry · 136

The role of myosin light chain kinase phosphorylation in beta-adrenergic relaxation of tracheal smooth muscle.

1983 · J R Miller, P J Silver, et al. · Molecular Pharmacology · 127

Role of low Km cyclic AMP phosphodiesterase inhibition in tracheal relaxation and bronchodilation in the guinea pig.

1989 · A L Harris, M J Connell, et al. · Journal of Pharmacology and Experimental Therapeutics · 111

Differential pharmacologic sensitivity of cyclic nucleotide phosphodiesterase isozymes isolated from cardiac muscle, arterial and airway smooth muscle

1988 · Paul J. Silver, Linda T. Hamel, et al. · European Journal of Pharmacology · 109

Adenosine 3‘:5‘-monophosphate-mediated inhibition of myosin light chain phosphorylation in bovine aortic actomyosin.

1979 · P.J. Silver, J. DiSalvo · Journal of Biological Chemistry · 105

Anti-tumor activities of chondroitinase AC and chondroitinase B: inhibition of angiogenesis, proliferation and invasion

2001 · Elizabeth M. Denholm, Yong-Qing Lin, et al. · European Journal of Pharmacology · 97

Phosphorylation of myosin light chain and phosphorylase in tracheal smooth muscle in response to KCl and carbachol.

1984 · P J Silver, J T Stull · Molecular Pharmacology · 84

Inhibition of the low Km cyclic AMP phosphodiesterase and activation of the cyclic AMP system in vascular smooth muscle by milrinone.

1988 · P J Silver, R E Lepore, et al. · Journal of Pharmacology and Experimental Therapeutics · 75

Adenosine-mediated relaxation and activation of cyclic AMP-dependent protein kinase in coronary arterial smooth muscle.

1984 · P J Silver, K Walus, et al. · Journal of Pharmacology and Experimental Therapeutics · 72

Quantitation of myosin light chain phosphorylation in small tissue samples.

1982 · P J Silver, J T Stull · Journal of Biological Chemistry · 71

Biochemical aspects of inhibition of cardiovascular low (Km) cyclic adenosine monophosphate phosphodiesterase

1989 · Paul J. Silver · The American Journal of Cardiology · 67

Zaprinast increases cyclic GMP levels in plasma and in aortic tissue of rats

1993 · Ronald L. Dundore, Dawn M. Clas, et al. · European Journal of Pharmacology · 62

Phosphodiesterase isozyme inhibition and the potentiation by zaprinast of endothelium-derived relaxing factor and guanylate cyclase stimulating agents in vascular smooth muscle.

1989 · A L Harris, B M Lemp, et al. · Journal of Pharmacology and Experimental Therapeutics · 62

Phosphodiesterase Isozyme Inhibition, Activation of the cAMP System, and Positive Inotropy Mediated by Milrinone in Isolated Guinea Pig Cardiac Muscle

1989 · Paul J. Silver, Alex L. Harris, et al. · Journal of Cardiovascular Pharmacology · 62

Ca2+ Dependent Phosphorylation of Bovine Aortic Actomyosin

1978 · J. DiSalvo, E. Gruenstein, et al. · Experimental Biology and Medicine · 57

Identification of a specific radioligand for the cardiac rapidly activating delayed rectifier K+ channel.

1993 · C C Chadwick, A M Ezrin, et al. · Circulation Research · 54

Differential Vasorelaxant Effects of Milrinone and Amrinone on Contractile Responses of Canine Coronary, Cerebral, and Renal Arteries

1989 · Alex L. Harris, Alison M. Grant, et al. · Journal of Cardiovascular Pharmacology · 45

Modulation of vascular and cardiac contractile protein regulatory mechanisms by calmodulin inhibitors and related compounds

1986 · Paul J. Silver, Patricia B. Pinto, et al. · Biochemical Pharmacology · 42

5,7-Dimethoxy-3-(4-Pyridinyl)Quinoline Is a Potent and Selective Inhibitor of Human Vascular .beta.-Type Platelet-Derived Growth Factor Receptor Tyrosine Kinase

1994 · Roland E. Dolle, Joseph A. Dunn, et al. · Journal of Medicinal Chemistry · 40

Regulation of Myosin Phosphorylation in Smooth Muscle

1984 · J. T. Stull, J. R. Miller, et al. · Developments in cardiovascular medicine · 40

Reversal of nitroglycerin tolerance in vitro by the cGMP-phosphodiesterase inhibitor zaprinast

1993 · Edward D. Pagani, Glenn S. VanAller, et al. · European Journal of Pharmacology · 36

Orally Bioavailable Benzisothiazolone Inhibitors of Human Leukocyte Elastase

1995 · Dennis J. Hlasta, Chakrapani Subramanyam, et al. · Journal of Medicinal Chemistry · 35

Novel and Potent Adenosine 3',5'-Cyclic Phosphate Phosphodiesterase III Inhibitors: Thiazolo[4,5-b][1,6]naphthyridin-2-ones

1995 · Baldev Singh, Edward R. Bacon, et al. · Journal of Medicinal Chemistry · 34

Effects of the calmodulin antagonist, fluphenazine, on phosphorylation of myosin and phosphorylase in intact smooth muscle.

1983 · P J Silver, J T Stull · Molecular Pharmacology · 33

Works count: 113

Citation count: 2,733

H-index: 27

I10-index: 63